Results 141 to 150 of about 35,915 (205)

A 3-month clofazimine-rifapentine-containing regimen for drug-susceptible tuberculosis versus standard of care (Clo-Fast): a randomised, open-label, phase 2c clinical trial. [PDF]

Lancet Infect Dis
Metcalfe JZ, Weir IR, Scarsi KK, Mendoza-Ticona A, Pierre S, Hall L, Leon-Cruz J, Svensson EM, Koele SE, Samaneka W, Kanyama C, Yohane M, Nevrekar N, Ntsalaze B, Marc JB, Goth M, Maartens G, Chaisson R, ACTG A5362 study team.   +18 more
europepmc   +1 more source

A catastrophic seven-year course of drug-resistant tuberculosis and lessons for multidisciplinary management: a case report. [PDF]

BMC Infect Dis
Fu L, Wang L, Bu X, Mo Y, Zheng Y, Deng G.   +5 more
europepmc   +1 more source

Rifapentine- and moxifloxacin-containing short-course regimens for mild spinal tuberculosis: study protocol for a multicenter, randomized, non-inferiority phase II clinical trial. [PDF]

Front Pharmacol
Wu YE, Cao J, Wang L, Wei YJ, Liu HX, Qi L, Zhang W, Liu F, Zhu ZJ, Fan XT, Wang S, Chen C, Liu XZ, Li Y, Sun ZZ, Pan JB, Yang CQ, Van Den Anker J, Zhang Q, Zhao W.   +19 more
europepmc   +1 more source

A Study of the Association of Cerebrospinal Fluid Neutrophil-to-Lymphocyte Ratio with Severity and Mortality in Patients with Tuberculous Meningitis. [PDF]

Ann Indian Acad Neurol
Mateen S, Siddiqi Z, Singh S, Singh A, Khan M.   +4 more
europepmc   +1 more source

Scaling-up diagnosis and treatment of drug-resistant tuberculosis in Khayelitsha, South Africa [PDF]

, 2011
MSF OCB, MSF South Africa
core   +1 more source

Preparation and in vitro sustained release performance of thermosensitive gel microsphere composite loaded with Anti-Tuberculosis drug PaMZ/BMP-2. [PDF]

J Orthop Surg Res
Li G, Song Q, Song Y, Liao W, Zhao D, Hong B, Cao G.   +6 more
europepmc   +1 more source

Predicting pyrazinamide resistance in Mycobacterium tuberculosis using a graph convolutional network

Dissanayake D, Morrone JA, Fowler PW.
europepmc   +1 more source

Rates and risk factors of monoresistance against isoniazid and multidrug-resistant tuberculosis in Almaty, Kazakhstan. [PDF]

BMC Infect Dis
Bartels JGE, Takenov N, Chingissova L, Rakisheva A, Eleusizova A, Bismilda V, Yeraliyeva L, Ben Amor Y.   +7 more
europepmc   +1 more source

Therapeutic drug monitoring-guided treatment of XDR TB with an RpoB I491F mutation-a case report. [PDF]

JAC Antimicrob Resist
Klingmüller A, Zuber S, Hoffmann AM, Köhler N, Suárez I, Preßel T, Niemann S, Dreyer V, Decosterd LA, Choong E, Schütz B, Friesen I, Rybniker J.   +12 more
europepmc   +1 more source